ProPhet News
2 articles
growth-positive
המהפכה בדרך: ה-AI עומד לשנות את תחום התרופות
ProPhet, a new Israeli startup, is leveraging artificial intelligence to significantly reduce the time and cost of discovering molecules that can be used as drugs. Founded by Tom Shani and Amitei Mordechai, the company emerged from AION Labs competitive startup challenge. ProPhet aims to revolutionize drug development by focusing on difficult-to-treat proteins and using AI to match molecules to proteins efficiently. The startup operates from AION Labs offices in Rehovot, Israel, benefiting from a collaborative ecosystem of scientists and entrepreneurs. AION Labs provides ProPhet with the necessary resources and connections to succeed in the pharmaceutical industry.
Partners
growth-positive
AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery
ProPhet, a new startup launched by AION Labs, aims to revolutionize drug discovery by leveraging artificial intelligence to identify active small molecules. The company addresses the need to accelerate and enhance early drug discovery stages, particularly for challenging protein targets. ProPhet utilizes advanced machine learning technologies to develop novel algorithms for evaluating protein conformational states and screening small molecule libraries. AION Labs, a venture studio backed by major pharmaceutical companies and investors, provides ProPhet with resources and industry connections. The startups founding team includes experts in biology, chemistry, and computational science, positioning it well for success in the pharmaceutical industry.
Partners
